- Home
- FBIOP vs SLF Comparison
FBIOP vs SLF Comparison
Compare FBIOP & SLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- SLF
- Stock Information
- Founded
- FBIOP N/A
- SLF 1871
- Country
- FBIOP United States
- SLF Canada
- Employees
- FBIOP 101
- SLF N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- SLF Advertising
- Sector
- FBIOP Health Care
- SLF Consumer Discretionary
- Exchange
- FBIOP Nasdaq
- SLF Nasdaq
- Market Cap
- FBIOP N/A
- SLF N/A
- IPO Year
- FBIOP N/A
- SLF N/A
- Fundamental
- Price
- FBIOP $6.15
- SLF $59.94
- Analyst Decision
- FBIOP
- SLF
- Analyst Count
- FBIOP 0
- SLF 0
- Target Price
- FBIOP N/A
- SLF N/A
- AVG Volume (30 Days)
- FBIOP N/A
- SLF 434.0K
- Earning Date
- FBIOP N/A
- SLF 05-08-2025
- Dividend Yield
- FBIOP N/A
- SLF 3.96%
- EPS Growth
- FBIOP N/A
- SLF N/A
- EPS
- FBIOP N/A
- SLF 3.65
- Revenue
- FBIOP N/A
- SLF $23,006,727,641.00
- Revenue This Year
- FBIOP N/A
- SLF N/A
- Revenue Next Year
- FBIOP N/A
- SLF $4.18
- P/E Ratio
- FBIOP N/A
- SLF $16.42
- Revenue Growth
- FBIOP N/A
- SLF 7.30
- 52 Week Low
- FBIOP N/A
- SLF $46.41
- 52 Week High
- FBIOP N/A
- SLF $62.85
- Technical
- Relative Strength Index (RSI)
- FBIOP 47.56
- SLF 62.50
- Support Level
- FBIOP $6.36
- SLF $56.08
- Resistance Level
- FBIOP $6.80
- SLF $60.34
- Average True Range (ATR)
- FBIOP 0.37
- SLF 0.77
- MACD
- FBIOP 0.01
- SLF 0.21
- Stochastic Oscillator
- FBIOP 45.52
- SLF 82.92
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.